DD
Therapeutic Areas
Mindstate Design Labs Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MSD-001 | Emotional & Cognitive Flexibility (Mental Health) | Phase 1 |
| MSD-X02 Series | Select Psychoactive Effects (CNS) | Preclinical |
| MSD-XXX Future Programs | Broad Psychoactive Effects (CNS) | Discovery |